Tianjin SinoBiotech Ltd.
7 clinical trials · Sponsor
◉ Watch Tianjin SinoBiotech Ltd.
| Record | Firm | Date |
|---|---|---|
| Study on Single Administration and Dose Increment of Recombinant Human Serum Albumin/Erythrocyte Fusion Protein for Injection (NCT03786289) | Tianjin SinoBiotech Ltd. | 2018-12-03 |
| Recombinant Human Serum Albumin/Granulocyte Colony Stimulating Factor Fusion Protein for Breast Cancer Patients (NCT03251768) | Tianjin SinoBiotech Ltd. | 2017-10-19 |
Track Tianjin SinoBiotech Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.